Malin Corporation | MLC - Ebitda

Stock Price
7.85
Daily Change
-0.15 -1.88%
Monthly
1.95%
Yearly
-23.04%
Q1 Forecast
7.76

Malin Corporation reported EUR-1.1M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
ALKERMES USD 121.55M 4.99M Sep/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Eurofins Scientific SE EUR 831M 21M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Lonza CHF 1.01B 54M Dec/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Moderna USD -208M 552M Sep/2025
Organon & Co USD 518M 4M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025